TR200100107T2 - Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. - Google Patents

Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.

Info

Publication number
TR200100107T2
TR200100107T2 TR2001/00107T TR200100107T TR200100107T2 TR 200100107 T2 TR200100107 T2 TR 200100107T2 TR 2001/00107 T TR2001/00107 T TR 2001/00107T TR 200100107 T TR200100107 T TR 200100107T TR 200100107 T2 TR200100107 T2 TR 200100107T2
Authority
TR
Turkey
Prior art keywords
polymer
pharmaceutical form
active ingredient
programmed
preparation
Prior art date
Application number
TR2001/00107T
Other languages
English (en)
Inventor
Gendrot Edouard
Cousin Gerard
Ragot Fran�Oise
Clee-Bouvet Marie-Christine
Original Assignee
Laboratoires Prographarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Prographarm filed Critical Laboratoires Prographarm
Publication of TR200100107T2 publication Critical patent/TR200100107T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bulus, aktif bilesenin saliniminin gecikmeli ve fasilali oldugu ve farmasötik formun alinmasindan sonra 4 ila 8 saat içinde aktif bilesenin kullanilabilmesini saglayan, ve daha sonra takip eden 8 ila 20 saat içinde aktif bilesenin tümünün sürekli olarak salinmasini saglayan bulusa göre olan çok parçacikli farmasötik form ile ilgilidir, ki özelligi organik asit içermemesi, ve içinde aktif bileseni olusturan parçaciklarin esit olarak dagildigi en az bir hidro-çözünebilir polimer ve en az bir hidro-çözünebilir olmayan polimer karisimina dayanan bir birinci kaplama içeren bir nötr küresel çekirdek, gastrik ve intestinel ortamlara göre birbirinden farkli geçirgenlik hizlari saglayan en az iki pH bagimsiz polimere, en az bir pH bagimli polimere, en az bir plastiklestiriciye ve esit olarak dagilmis en az bir inert tasiyiciya dayanan bir ikinci kaplama içeren tibbi küreler formunda olmasidir.
TR2001/00107T 1998-05-20 1999-05-20 Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem. TR200100107T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (1)

Publication Number Publication Date
TR200100107T2 true TR200100107T2 (tr) 2001-06-21

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00107T TR200100107T2 (tr) 1998-05-20 1999-05-20 Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.

Country Status (25)

Country Link
EP (1) EP1077687B1 (tr)
JP (1) JP2002515423A (tr)
KR (1) KR100583065B1 (tr)
CN (1) CN1186014C (tr)
AT (1) ATE214598T1 (tr)
AU (1) AU758299B2 (tr)
BG (1) BG64764B1 (tr)
BR (1) BR9910606A (tr)
CA (1) CA2333188C (tr)
DE (1) DE69901062T2 (tr)
DK (1) DK1077687T3 (tr)
ES (1) ES2173739T3 (tr)
FR (1) FR2778848B1 (tr)
GE (1) GEP20022750B (tr)
HK (1) HK1033271A1 (tr)
HU (1) HU224193B1 (tr)
IL (1) IL139774A (tr)
MX (1) MXPA00011364A (tr)
NO (1) NO330501B1 (tr)
NZ (1) NZ508392A (tr)
PL (1) PL192950B1 (tr)
PT (1) PT1077687E (tr)
TR (1) TR200100107T2 (tr)
WO (1) WO1999059557A1 (tr)
ZA (1) ZA200006768B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
NO20005838L (no) 2001-01-10
BG104963A (en) 2001-07-31
AU3830299A (en) 1999-12-06
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
AU758299B2 (en) 2003-03-20
WO1999059557A1 (fr) 1999-11-25
CA2333188A1 (fr) 1999-11-25
IL139774A0 (en) 2002-02-10
FR2778848A1 (fr) 1999-11-26
DK1077687T3 (da) 2002-06-17
MXPA00011364A (es) 2008-09-09
NO20005838D0 (no) 2000-11-17
HUP0102027A2 (hu) 2002-03-28
KR100583065B1 (ko) 2006-06-08
ATE214598T1 (de) 2002-04-15
BG64764B1 (bg) 2006-03-31
CN1186014C (zh) 2005-01-26
CN1305371A (zh) 2001-07-25
PL344314A1 (en) 2001-10-22
CA2333188C (fr) 2010-07-06
JP2002515423A (ja) 2002-05-28
HK1033271A1 (en) 2001-08-24
ZA200006768B (en) 2001-11-20
DE69901062D1 (de) 2002-04-25
NO330501B1 (no) 2011-05-02
DE69901062T2 (de) 2002-10-31
HU224193B1 (hu) 2005-06-28
BR9910606A (pt) 2001-10-02
GEP20022750B (en) 2002-08-26
HUP0102027A3 (en) 2002-12-28
EP1077687A1 (fr) 2001-02-28
EP1077687B1 (fr) 2002-03-20
ES2173739T3 (es) 2002-10-16
KR20010052370A (ko) 2001-06-25
PT1077687E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
TR200100107T2 (tr) Programlı ve fasılalı salınımlı çok parçacıklı farmasötik form ve hazırlanması için işlem.
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
AU2001239658A1 (en) Method for producing a controlled-release preparation
AU7495596A (en) Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process
EP1397200B1 (de) Auflösbare nano- und mikrokapseln, verfahren zu ihrer herstellung sowie ihre verwendung
HUP0004732A2 (hu) Kapszulázási eljárás
FR2775435B1 (fr) Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
TR199901564T2 (tr) Hizli çözülebilen ve tat-maskesi saglayan dozaj ispençiyari formu.
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
DE3850826T2 (de) Polymere, nichtwässerige Dispersionen, Verfahren zu deren Herstellung und Beschichtungszusammensetzungen.
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
DE69526434D1 (de) Metronidazolpräparate mit modifizierter freisetzung und verfahren für ihre herstellung und verwendung
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
CA2163539A1 (en) N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes
FR2791569B1 (fr) Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
ATE364403T1 (de) Retardtablette hergestellt aus linearen wasserunlöslichen polysacchariden
ATE218371T1 (de) Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung
HUP0202895A2 (hu) Eljárás késleltetett hatóanyag-leadású komplexek előállítására
JPS5318646A (en) Soil conditioner
HUP9901338A2 (hu) Eljárás kinolon-karbonsavak vagy naftiridin-karbonsavak előállítására szabad bázis formájú alakban
CA2617351A1 (en) Diltiazem controlled release formulation and method of manufacture
JPS5590517A (en) Water-containing gel
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
TH20029B (th) ควิโนโลนคาร์บอกซิลิค แอซิดที่ถูกแทนที่ด้วย n-หมู่ใดๆ 6-ฟลูออโร-8-ไดฟลูออโรเมธอกซีที่เป็นสารชนิดใหม่
KR970014762A (ko) 하이드로겔을 사용한 매트릭스형 경피투여시스템